Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bridging in vitro and clinical data: Experimental insights into the IC50 variability of dolutegravir as an organic cation transporter 2 inhibitor. | Drug Metab Dispos | 2025 | 40460516 | PubTator, text mining | PubMed |
| Evaluating the utility of endogenous OCT2 and MATE1/2-K biomarkers for DDI assessment in early clinical settings. | J Pharm Sci | 2025 | 40445153 | PubTator, text mining | PubMed |
| Molecular Ancestry Across Allelic Variants of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Mexican-Mestizo DMT2 Patients. | Biomedicines | 2025 | 40426982 | PubTator, text mining | PubMed |
Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium). | Clin Pharmacol Ther | 2025 | 40424011 | PubTator, text mining | PubMed |
| Molecular pharmacokinetic mechanism of JBP485 against aristolochic acid I (AAI) -induced nephrotoxicity. | Front Pharmacol | 2025 | 40371353 | PubTator, text mining | PubMed |
| Substrate-specific inhibition of organic cation transporter 1 revealed using a multisubstrate drug cocktail. | Drug Metab Dispos | 2025 | 40319555 | PubTator, text mining | PubMed |
| Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic review. | Crit Rev Oncol Hematol | 2025 | 40222694 | PubTator, text mining | PubMed |
| Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions. | Precis Clin Med | 2025 | 40110576 | PubTator, text mining | PubMed |
| Quantitative Contributions of Hepatic and Renal Organic Cation Transporters to the Clinical Pharmacokinetic Cimetidine-Metformin Interaction. | Clin Pharmacol Ther | 2025 | 40098288 | PubTator, text mining | PubMed |
| Both carvedilol and cimetidine alleviate cisplatin-induced nephrotoxicity via downregulating OCT2. | Biochim Biophys Acta Mol Basis Dis | 2025 | 40044066 | PubTator, text mining | PubMed |
| Identification of selective substrates and inhibitors of the major human renal uptake transporters. | Drug Metab Dispos | 2025 | 40024137 | PubTator, text mining | PubMed |
| Organic cation transporters 2: Structure, regulation, functions, and clinical implications. | Drug Metab Dispos | 2025 | 40020559 | PubTator, text mining | PubMed |
| Stopping bosutinib reverses bosutinib-induced elevation of serum creatinine in patients with chronic myeloid leukemia. | Int J Hematol | 2025 | 40000571 | PubTator, text mining | PubMed |
| Is N1-Methylnicotinamide a Good Organic Cation Transporter 2 (OCT2) Biomarker? | Metabolites | 2025 | 39997705 | PubTator, text mining | PubMed |
| Using cimetidine to mitigate cisplatin-induced ototoxicity. | Toxicol In Vitro | 2025 | 39947413 | PubTator, text mining | PubMed |
| PCK1 and SLC22A2 gene variants associated with response to metformin treatment in type 2 diabetes. | PLoS One | 2025 | 39928707 | PubTator, text mining | PubMed |
| Protective effects of MET channels on aminoglycosides- and cisplatin-induced ototoxicity. | Int J Med Sci | 2025 | 39898250 | PubTator, text mining | PubMed |
| Comparative analysis of the physiological and transport functions of various sources of renal proximal tubule cells under static and fluidic conditions in PhysioMimix T12 platform. | Drug Metab Dispos | 2025 | 39884810 | PubTator, text mining | PubMed |
| Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model. | Sci Rep | 2025 | 39833227 | PubTator, text mining | PubMed |
| Effects of Xhosa specific solute carrier family 22-member 2 haplotypes on the cellular uptake of metformin and cimetidine. | Gene | 2025 | 39653092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=4